Moderna has presented its new, promising cancer vaccine, which reduced the recurrence of melanoma by 42% during the first major clinical trial, but it is still unknown how effective it will be for other types of cancer. #rákellenesvakcina #Moderna #mRNS (translated)
telex.hu
Ígéretes rákellenes vakcinát mutatott be a Moderna
